by MarketingPNO | Apr 15, 2026 | News
Wouter van den Heijden (AUMC) Presentation: First evaluation of a S100A8/S100A9-specific nanobody to assess phagocyte-driven inflammatory activity in a murine arthritis model in vivo With a strong focus on treatment evaluation, Wouter van den Heijden presented...
by MarketingPNO | Apr 15, 2026 | News
Melinda Badenhorst (AUMC) Presentation: In vivo evaluation of non-competitive 89Zr-labeled nanobody tracers targeting Focusing on the clinical application of immune imaging, Melinda Badenhorst presented her work on how molecular imaging techniques can support...
by MarketingPNO | Apr 15, 2026 | News
Presenting author: Sven Hermann (WWU) Sven Hermann presented advanced approaches in molecular imaging aimed at improving the understanding of biological processes at a detailed level. His work focuses on how imaging technologies can be used to study disease...
by MarketingPNO | Apr 15, 2026 | News
Presenting author: Marc Neumann (EKUT) Focusing on the robustness and reliability of imaging methodologies, Marc Neumann presented work on preclinical imaging and tracer validation. His research emphasises the importance of ensuring that newly developed tracers and...
by MarketingPNO | Apr 15, 2026 | News
Presenting author: Roman Mehling (EKUT) Roman Mehling’s work explores how molecular imaging can be used to better understand immunological processes in complex disease models. His research focuses on refining imaging approaches that allow for more detailed tracking of...
![Development of a novel Al[18F]F-RESCA labelled CD163-specific PET tracer](https://www.immune-image.eu/wp-content/uploads/2026/04/Marie_Poster-1080x675.jpeg)
by MarketingPNO | Apr 15, 2026 | News
Presenting author: Marie Velada Dugois (AUMC) Building on the growing need for more precise immune cell imaging tools, Marie Velada Dugois presented her work on the development of a novel Al[18F]F-RESCA-labelled CD163-specific PET tracer. CD163 is associated with...
Recent Comments